MedTrace Logo

The Effect of Curcumin Against Colistin-induced Nephrotoxicity

NCT05613361 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 214

Last updated 2023-10-31

No results posted yet for this study

Summary

The goal of this study is to investigate the possible nephroprotective effect of curcumin in critically ill patients receiving colistin.

Conditions

Interventions

DRUG

Colistin

added for infection with multi drug resistant bacteria

DRUG

Curcumin

added for the possible nephroprotective effect

Sponsors & Collaborators

  • Cairo University

    collaborator OTHER

  • October 6 University

    lead OTHER

Principal Investigators

  • Nirmeen A. Sabry · Professor of Clinical Pharmacy Faculty of Pharmacy Cairo University

  • Maggie M. Abbassi · Professor of Clinical Pharmacy Faculty of Pharmacy Cairo University

  • Rania El-Husseiny · Professor of Critical Care Medicine, Faculty of Medicine Cairo University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-04-30
Completion
2024-10-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613361 on ClinicalTrials.gov